Retinal Ganglion Cells In Glaucoma is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Glaucoma is characterized by progressive degeneration of retinal ganglion cells (RGCs), leading to irreversible vision loss. It represents a neurodegenerative disease of the retina.
- Midget RGCs: Parvocellular pathway
- Parasol RGCs: Magnocellular pathway
- Intrinsically photosensitive (ipRGCs): Non-image forming
RGCs:
- Transmit visual information to brain
- Project via optic nerve
- Support circadian rhythm
- Enable image formation
RGCs show:
- Apoptotic cell death
- Dendritic retraction
- Axonal loss at optic nerve head
- Progressive visual field loss
- Elevated intraocular pressure
- Age
- Family history
- Vascular factors
- Mechanical stress
- Impaired axonal transport
- Ischemia
- Excitotoxicity
Common pathways:
- Oxidative stress
- Mitochondrial dysfunction
- Neuroinflammation
- Protein aggregation
- Neurotrophic factors
- Antioxidants
- Anti-apoptotic agents
- Calcium channel blockers
Research directions:
- Stem cell transplantation
- Gene therapy
- Optic nerve regeneration
- Activity-dependent plasticity
The study of Retinal Ganglion Cells In Glaucoma has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Quigley (2011). Ganglion cell death in glaucoma. Progress in Retinal Eye Research
- Weinreb et al. (2014). Glaucoma. Lancet
- You et al. (2020). RGC neuroprotection. Nature Reviews Neurology